Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Durect Corporation stock

Learn how to easily invest in Durect Corporation stock.

Durect Corporation is a drug manufacturers-specialty & generic business based in the US. Durect Corporation shares (DRRX) are listed on the NASDAQ and all prices are listed in US Dollars. Durect Corporation employs 78 staff and has a trailing 12-month revenue of around $13.5 million.

How to buy shares in Durect Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DRRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Durect Corporation stock price (NASDAQ: DRRX)

Use our graph to track the performance of DRRX stocks over time.

Durect Corporation shares at a glance

Information last updated 2022-10-04.
Latest market close$0.59
52-week range$0.36 - $1.32
50-day moving average $0.65
200-day moving average $0.62
Wall St. target price$5.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.16

Buy Durect Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Durect Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Durect Corporation price performance over time

Historical closes compared with the close of $0.59 from 2022-10-03

1 week (2022-09-28) 5.34%
1 month (2022-09-02) -18.06%
3 months (2022-07-05) 28.26%
6 months (2022-04-04) 1.72%
1 year (2021-10-05) -50.00%
2 years (2020-10-05) -68.78%
3 years (2019-10-04) 1.87
5 years (2017-10-04) 1.99

Durect Corporation financials

Revenue TTM $13.5 million
Gross profit TTM $-19,824,000
Return on assets TTM -26.54%
Return on equity TTM -71.49%
Profit margin -292.71%
Book value $0.16
Market capitalisation $134.3 million

TTM: trailing 12 months

Durect Corporation share dividends

We're not expecting Durect Corporation to pay a dividend over the next 12 months.

Durect Corporation share price volatility

Over the last 12 months, Durect Corporation's shares have ranged in value from as little as $0.36 up to $1.32. A popular way to gauge a stock's volatility is its "beta".

DRRX.US volatility(beta: 1.2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Durect Corporation's is 1.1998. This would suggest that Durect Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Durect Corporation overview

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd. ; and Santen Pharmaceutical Co.

Frequently asked questions

What percentage of Durect Corporation is owned by insiders or institutions?
Currently 1.564% of Durect Corporation shares are held by insiders and 45.619% by institutions.
How many people work for Durect Corporation?
Latest data suggests 78 work at Durect Corporation.
When does the fiscal year end for Durect Corporation?
Durect Corporation's fiscal year ends in December.
Where is Durect Corporation based?
Durect Corporation's address is: 10260 Bubb Road, Cupertino, CA, United States, 95014-4166
What is Durect Corporation's ISIN number?
Durect Corporation's international securities identification number is: US2666051048
What is Durect Corporation's CUSIP number?
Durect Corporation's Committee on Uniform Securities Identification Procedures number is: 266605104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site